Medicine Atlas

How Healing Is Practiced
Sign In
Text size
100%
Theme
Condition

Sneddon's syndrome

Diseases of the Circulatory System

Sneddon's syndrome is a progressive, noninflammatory arteriopathy characterized by severe transient neurological symptoms or stroke together with a skin rash called livedo reticularis, a bluish-purple netlike mottling of the skin, or the larger-patched livedo racemosa. The skin signs usually appear first, often in the extremities and worse in the cold, and may precede neurological problems by years. Other features can include transient amnesia, transient aphasia, headaches, hypertension, transient ischemic attacks, coronary disease and, late in the course, dementia. It is named for Ian Bruce Sneddon, who in 1965 reported six patients with this rash and cerebrovascular accidents. It was formerly regarded as a form of antiphospholipid syndrome but has been reclassified as a noninflammatory cerebrovascular disease, although about 40 to 60 percent of patients test positive for antiphospholipid antibodies. No single test is abnormal in every patient, though brain MRI and skin biopsy often are, and diagnosis rests on history and examination. Patients are generally treated with warfarin at a high INR of 3 to 4. It is rare, usually misdiagnosed, most often apparent in women in their thirties, and may be inherited in an autosomal dominant fashion. This entry records what is documented and is not medical advice.

Facts
First Described
1965 2
Prevalence Band
Rare (Under 1 in 2000) 1
Eradicated or Controlled
Ongoing 1
Classification
Body System
Cardiovascular System 1
Causative Agent
Causative Agent (category)
Idiopathic / Multifactorial 1
Connections

Discovered By

Source Sneddon's syndrome (Wikipedia)

Treats

Source Sneddon's syndrome (Wikipedia)
Sources
1. Cleveland Clinic: Sneddon Syndrome
Cleveland Clinic
  • Overview
    Sneddon syndrome is a disease that affects your small and medium blood vessels.
  • Symptoms and Causes, causes
    so, it’s called idiopathic
  • Overview, how common
    Sneddon syndrome affects an estimated 4 per 1 million people per year (or 1 in 250,000 people).
  • Outlook, cure
    Currently, there isn’t a cure for Sneddon syndrome.
View the Source
2. National Organization for Rare Disorders: Sneddon Syndrome
National Organization for Rare DisordersIntroduction
Quote, Introduction
Sneddon syndrome was first described a separate clinical entity in the medical literature by Dr. Sneddon and colleagues in 1965.
View the Source
Sneddon's syndrome (Wikipedia)
  • Treats: Anticoagulant Therapy, Treatment
    Sneddon's patients are generally treated with warfarin
  • Discovered By: Ian Bruce Sneddon, History
    It is named for Ian Bruce Sneddon.
View the Source
Comments (0)
No comments yet. Be the first to share a thought.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.